nelfinavir has been researched along with Drug Abuse, Intravenous in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atluri, VSR; Jayant, RD; Kaushik, A; Nair, M; Pilakka-Kanthikeel, S; Tiwari, S; Yndart, A | 1 |
| Daniels, E; Hsyu, PH; Kerr, BM; Lillibridge, J | 1 |
| Arnedo, A; Gómez, CJ; Roca, B | 1 |
| Bamberger, JD; Chambers, D; Chesney, M; Coates, TJ; Franses, K; Kahn, JO; Katz, MH; Martin, JN; Roland, ME | 1 |
1 trial(s) available for nelfinavir and Drug Abuse, Intravenous
| Article | Year |
|---|---|
Pharmacokinetic interaction of nelfinavir and methadone in intravenous drug users.
Topics: Administration, Oral; Adult; Drug Interactions; Female; HIV Protease Inhibitors; Humans; Male; Methadone; Middle Aged; Narcotics; Nelfinavir; Prospective Studies; Substance Abuse, Intravenous | 2006 |
3 other study(ies) available for nelfinavir and Drug Abuse, Intravenous
| Article | Year |
|---|---|
Novel nanoformulation to mitigate co-effects of drugs of abuse and HIV-1 infection: towards the treatment of NeuroAIDS.
Topics: AIDS Dementia Complex; Astrocytes; Blood-Brain Barrier; Carbazoles; Cocaine; Delayed-Action Preparations; Endothelial Cells; HIV Protease Inhibitors; HIV-1; Humans; Illicit Drugs; Magnets; Methamphetamine; Nanostructures; Nelfinavir; Neuroprotective Agents; Primary Cell Culture; Substance Abuse, Intravenous | 2017 |
Adherence, side effects and efficacy of stavudine plus lamivudine plus nelfinavir in treatment-experienced HIV-infected patients.
Topics: Adult; CD4 Lymphocyte Count; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis C; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Logistic Models; Male; Nelfinavir; Patient Compliance; Polymerase Chain Reaction; Prospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Statistics, Nonparametric; Stavudine; Substance Abuse, Intravenous | 2000 |
Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Contact Tracing; Counseling; Didanosine; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nelfinavir; Patient Compliance; Reverse Transcriptase Inhibitors; Risk Factors; Risk-Taking; Sexually Transmitted Diseases, Viral; Substance Abuse, Intravenous; Time Factors; Zidovudine | 2001 |